These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12746434)

  • 21. p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.
    Issbrücker K; Marti HH; Hippenstiel S; Springmann G; Voswinckel R; Gaumann A; Breier G; Drexler HC; Suttorp N; Clauss M
    FASEB J; 2003 Feb; 17(2):262-4. PubMed ID: 12490545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
    Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
    Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells.
    Kim KS; Hong YK; Joe YA; Lee Y; Shin JY; Park HE; Lee IH; Lee SY; Kang DK; Chang SI; Chung SI
    J Biol Chem; 2003 Mar; 278(13):11449-56. PubMed ID: 12529357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
    Yi ZF; Cho SG; Zhao H; Wu YY; Luo J; Li D; Yi T; Xu X; Wu Z; Liu M
    Int J Cancer; 2009 Feb; 124(4):843-52. PubMed ID: 19035465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
    Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells.
    Redlitz A; Daum G; Sage EH
    J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer.
    Bianco C; Tortora G; Baldassarre G; Caputo R; Fontanini G; Chinè S; Bianco AR; Ciardiello F
    Clin Cancer Res; 1997 Mar; 3(3):439-48. PubMed ID: 9815703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
    Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
    Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
    Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
    Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of apolipoprotein(a) on in vitro angiogenesis.
    Schulter V; Koolwijk P; Peters E; Frank S; Hrzenjak A; Graier WF; van Hinsbergh VW; Kostner GM
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):433-8. PubMed ID: 11231925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3).
    Licht T; Tsirulnikov L; Reuveni H; Yarnitzky T; Ben-Sasson SA
    Blood; 2003 Sep; 102(6):2099-107. PubMed ID: 12763936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
    Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.